Published in Cell on May 04, 2017
Heavy Metal Enlightens Tumor Immunity. Cell (2017) 0.75
Cell maps reveal fresh details on how the immune system fights cancer. Nature (2017) 0.75
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade. Cell (2017) 0.75
Unmassked: Single-Cell Profiling of Immune Cell Populations in Tumors. Mol Ther (2017) 0.75
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics (2009) 67.17
Immunity, inflammation, and cancer. Cell (2010) 28.27
STAR: ultrafast universal RNA-seq aligner. Bioinformatics (2012) 25.21
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (2006) 24.54
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (2011) 15.79
Macrophage diversity enhances tumor progression and metastasis. Cell (2010) 13.41
T cell exhaustion. Nat Immunol (2011) 11.08
Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity (2014) 7.26
Natural innate and adaptive immunity to cancer. Annu Rev Immunol (2011) 7.09
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood (2009) 6.17
Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods (2006) 5.25
CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med (2013) 5.04
Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem (2009) 4.95
viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat Biotechnol (2013) 4.88
Tumor-associated macrophages: from mechanisms to therapy. Immunity (2014) 4.69
Macrophage polarization in tumour progression. Semin Cancer Biol (2008) 4.62
Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity (2014) 3.94
Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators. Nat Biotechnol (2012) 3.65
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol (2014) 3.21
Highly multiparametric analysis by mass cytometry. J Immunol Methods (2010) 2.77
Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol (2015) 2.74
Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol (2014) 2.71
Normalization of mass cytometry data with bead standards. Cytometry A (2013) 2.63
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods (2014) 2.62
Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res (2010) 2.48
Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom (2010) 2.43
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell (2014) 2.40
CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity (2010) 2.37
Immune cell promotion of metastasis. Nat Rev Immunol (2015) 2.15
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science (2016) 1.95
A platinum-based covalent viability reagent for single-cell mass cytometry. Cytometry A (2012) 1.69
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next? Curr Opin Immunol (2015) 1.68
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis. Cell (2015) 1.67
Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol (2015) 1.61
Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm. Nat Protoc (2015) 1.57
CD169+ macrophages at the crossroads of antigen presentation. Trends Immunol (2011) 1.44
Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am J Transl Res (2012) 1.37
Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma. Oncoimmunology (2013) 1.35
Diffusion maps for high-dimensional single-cell analysis of differentiation data. Bioinformatics (2015) 1.33
New insights into the multidimensional concept of macrophage ontogeny, activation and function. Nat Immunol (2015) 1.31
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer (2013) 1.27
Molecular aspects of renal cell carcinoma: a review. Am J Cancer Res (2010) 1.25
Prognostic value of diametrically polarized tumor-associated macrophages in renal cell carcinoma. Ann Surg Oncol (2014) 1.18
Transient partial permeabilization with saponin enables cellular barcoding prior to surface marker staining. Cytometry A (2014) 1.18
Novel Markers to Delineate Murine M1 and M2 Macrophages. PLoS One (2015) 1.13
QuasR: quantification and annotation of short reads in R. Bioinformatics (2014) 1.12
destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics (2015) 1.09
Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma. Transl Oncol (2013) 1.08
Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci (2013) 1.08
Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma. Cancer Sci (2013) 0.98
Dual role of CD38 in microglial activation and activation-induced cell death. J Immunol (2008) 0.96
Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy. Clin Cancer Res (2016) 0.95
CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. Cancer Sci (2013) 0.94
CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients. Oncotarget (2015) 0.92
Immune signature of tumor infiltrating immune cells in renal cancer. Oncoimmunology (2015) 0.91
A practical guide to multiplexed mass cytometry. Curr Top Microbiol Immunol (2014) 0.90
CD4+/CD8+ double-positive T cells: more than just a developmental stage? J Leukoc Biol (2014) 0.90
Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. J Clin Invest (2016) 0.89
It's DE-licious: A Recipe for Differential Expression Analyses of RNA-seq Experiments Using Quasi-Likelihood Methods in edgeR. Methods Mol Biol (2016) 0.89
Inhibition of glioma progression by a newly discovered CD38 inhibitor. Int J Cancer (2014) 0.86
CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer. Cancer Res (2015) 0.84
CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages. Neuro Oncol (2012) 0.82
Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma. Int J Urol (2015) 0.82
Regulatory circuits of T cell function in cancer. Nat Rev Immunol (2016) 0.81
AirLab: a cloud-based platform to manage and share antibody-based single-cell research. Genome Biol (2016) 0.79
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection. PLoS Pathog (2016) 0.77
Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice. Urol Oncol (2017) 0.77